NanoString Blog
Neuroscience Q&A
Rediscovering Microglia: Dr. Oleg Butovsky Discusses the Untapped Potential of Microglia in Neurodegenerative Diseases
Oleg Butovsky, Ph.D., is an Assistant Professor of Neurology at Harvard Medical School. His laboratory at the Center of Neurologic Diseases in Brigham & Women’s Hospital focuses on the basic…
Neuroscience
Advancing Neuroscience Gene Expression Research
The Neuropathology and Neuroinflammation panels are the newest addition to NanoString’s curated gene expression content poised to accelerate the pace of discovery in Alzheimer’s Disease (AD), Parkinson’s Disease, Huntington’s Disease…
Digital Spatial Profiling
Breaking Boundaries with NanoString’s Digital Spatial Profiling
Recently we had a conversation with key members of the scientific leadership team at NanoString. Joe Beechem, the Senior VP of Research & Development, and Alessandra Cesano, Chief Medical Officer,…
Neuroscience
Design of a 770-plex Gene List for the Comprehensive Study of Neurodegeneration: The NanoString® Process
Interested in performing comprehensive multiplex gene expression analysis covering six fundamental themes of neurodegeneration: neurotransmission, neuron-glia interaction, neuroplasticity, cell structure integrity, neuroinflammation and metabolism? Wondering how you can narrow down these complex…
Miscellaneous
Highlights from SITC 2017
It’s been an exciting and productive annual meeting for the Society for Immunotherapy of Cancer (SITC) 2017, full of ground-breaking science to share when back in the lab. For those…
Data Analysis
These Will Change Your (Quantitative Data Analysis) Life and Here’s Why
Your data doesn’t fit in a box Gone are the days of assay-specific data analysis. nSolver 4.0 is analyte focused and less assay restricted. This means that any combination of…
Data Analysis
Welcome to the nSolver™ Software Tech Blog!
We love that you’re here. Here’s why you’re going to love it, too: Fun-size articles on nSolver & Advanced Analysis. In between scientific papers, grant applications, and your other lengthy…
Digital Spatial Profiling Q&A
Characterizing Severe Autoimmune Toxicities Associated with Checkpoint Inhibitor Therapies
Immune checkpoint inhibitors (ICI) have emerged as powerful tools against cancer but in some cases have caused inflammation of organ systems that contributed to morbidity or mortality in patients. The…
Oncology
The IO Revolution, Part 3 of 4: The Role of the Tumor in the Cancer Immunity Cycle
Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this…
Oncology
The IO Revolution, Part 2 of 4: The Role of the Host in the Cancer Immunity Cycle
Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. In the next few blogs, we will consider how each of these…
Miscellaneous Oncology
Presidents, Rock Stars and Companion Diagnostics: 2016 Review of Immunotherapy
President Jimmy Carter announced this spring that he no longer needed treatments for the metastatic melanoma found in his brain–after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer…
Events
ASH 2016: Subtyping in Diffuse Large B-Cell Lymphoma
NanoString at ASH 2016. We attended the annual meeting of the American Society of Hematology (ASH) in San Diego. The convention center was abuzz with scientists…